학술논문
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2.
Document Type
Article
Author
Wilkinson, Tom; De Soyza, Anthony; Carroll, Miles; Chalmers, James D.; Crooks, Michael G.; Griffiths, Gareth; Shankar-Hari, Manu; Ling-Pei Ho; Horsley, Alex; Kell, Chris; Lara, Beatriz; Mishra, Biswa; Moate, Rachel; Page, Clive; Pandya, Hitesh; Raw, Jason; Reid, Fred; Saralaya, Dinesh; Scott, Ian C.; Siddiqui, Salman
Source
ERJ Open Research; Sep2023, Vol. 9 Issue 5, p1-13, 13p
Subject
Language
ISSN
23120541